Literature DB >> 225341

Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.

D C Kem, M H Weinberger, J R Higgins, N J Kramer, C Gomez-Sanchez, O B Holland.   

Abstract

ACTH alpha 1-24 was infused at incremental rates of 12.5-200 mIU/30 min in dexamethasone-suppressed hypertensive patients on a regular sodium diet. The plasma aldosterone response to this stimulus in 8 patients with hyperaldosteronism due to an adrenal aldenoma and 11 with adrenal hyperplasia was significantly greater at all infusion rates (P less than 0.05) when compared with the response in 6 normal subjects on a similar diet. This responsiveness to ACTH in the patients with primary hyperaldosteronism was similar to that of the normal subjects on a low sodium diet. Twelve patients with low renin and 6 patients with normal renin essential hypertension were similarly studied. There was no significant difference in the median aldosterone response between these 2 groups and the normal subjects on a normal diet, but the response was significantly lower compared with that in patients with primary hyperaldosteronism. These data show that patients with hyperaldosteronism from an adrenal adenoma or hyperplasia have a consistent and exaggerated response to ACTH. The hyper-responsiveness is not apparently shared by the majority of patients with low renin essential hypertension and does not support the concept that this group is an intermediate form of primary aldosteronism. Individual patients within this group, however, may have such a response and might be identified by this type of testing.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 225341     DOI: 10.1210/jcem-46-4-552

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

2.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 3.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

4.  Cosyntropin stimulation in adrenal vein testing for aldosteronoma.

Authors:  R H Noth; S L Glaser; J C Palmaz
Journal:  West J Med       Date:  1985-01

5.  The adrenal receptor for angiotensin II is altered in essential hypertension.

Authors:  G H Williams; N K Hollenberg; T J Moore; S L Swartz; R G Dluhy
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 6.  Low-renin hypertension of childhood.

Authors:  J DiMartino-Nardi; M I New
Journal:  Pediatr Nephrol       Date:  1987-01       Impact factor: 3.714

Review 7.  Cellular origin of aldosteronomas.

Authors:  A Ganguly
Journal:  Clin Investig       Date:  1992-05

Review 8.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

9.  Aldosterone suppression with dopamine infusion in low-renin hypertension.

Authors:  O B Holland; C Thomas; H Brown; D Schindewolf; Y Hillier; C Gomez-Sanchez
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  Role of adrenocorticotropic hormone in essential hypertension and primary aldosteronism.

Authors:  Decio Armanini; Alessandra Andrisani; Guido Ambrosini; Luciana Bordin; Chiara Sabbadin
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.